Location: New Haven CT, Trumbull CT, Fairfax VA, Nashville TN,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07519655
Phase1, Recruiting
Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)
for
Breast Cancer, Lung Cancer, Melanoma, Gynecologic Cancer,
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT07524114
Recruiting
A Study of BI 3810944 in Patients With Advanced Cancer
for
Solid Tumours, Melanoma
Location: Louisville KY, Nashville TN
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07224425
Phase1, Recruiting
Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver
for
Uveal Melanoma
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT07364474
Recruiting
Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma
for
Melanoma Metastatic
Location: Toronto
Sponsor: Melanoma Institute Australia
Sex: All
Age: 18+
Code: NCT06767306
Phase2, Recruiting
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
for
Refractory Melanoma
Location: Boston MA, Morristown NJ, Chapel Hill NC, Birmingham AL,
Sponsor: Diakonos Oncology Corporation
Sex: All
Age: 18+
Code: NCT07288112
Phase1, Phase2, Recruiting
Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically
for
Non-Melanoma Skin Cancer (NMSC), Benign Skin Growth
Location: Lebanon NH
Sponsor: Dartmouth-Hitchcock Medical Center
Sex: All
Age: 18+
Code: NCT07201376
Recruiting
Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients
for
Melanoma
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07379138
Recruiting
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3